These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12587254)

  • 1. 1,3-Butadiene: exposure estimation, hazard characterization, and exposure-response analysis.
    Hughes K; Meek ME; Walker M; Beauchamp R
    J Toxicol Environ Health B Crit Rev; 2003; 6(1):55-83. PubMed ID: 12587254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health risk assessment of 1,3-butadiene as a Priority Substance in Canada.
    Hughes K; Meek ME; Walker M
    Chem Biol Interact; 2001 Jun; 135-136():109-35. PubMed ID: 11397385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroform: exposure estimation, hazard characterization, and exposure-response analysis.
    Meek ME; Beauchamp R; Long G; Moir D; Turner L; Walker M
    J Toxicol Environ Health B Crit Rev; 2002; 5(3):283-334. PubMed ID: 12162870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled formaldehyde: exposure estimation, hazard characterization, and exposure-response analysis.
    Liteplo RG; Meek ME
    J Toxicol Environ Health B Crit Rev; 2003; 6(1):85-114. PubMed ID: 12587255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,3-Butadiene: III. Assessing carcinogenic modes of action.
    Kirman CR; Albertini RA; Gargas ML
    Crit Rev Toxicol; 2010 Oct; 40 Suppl 1():74-92. PubMed ID: 20868268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
    Preston RJ
    Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene.
    Booth ED; Kilgour JD; Watson WP
    Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,3-Butadiene: I. Review of metabolism and the implications to human health risk assessment.
    Kirman CR; Albertini RJ; Sweeney LM; Gargas ML
    Crit Rev Toxicol; 2010 Oct; 40 Suppl 1():1-11. PubMed ID: 20868266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 434():1-389. PubMed ID: 12616297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace.
    Bond JA; Recio L; Andjelkovich D
    Carcinogenesis; 1995 Feb; 16(2):165-71. PubMed ID: 7859344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating ambient concentration and cancer risk for 1,3-butadiene in Japan.
    Mita K; Higashino H; Yoshikado H; Nakanishi J
    Environ Sci; 2006; 13(1):1-13. PubMed ID: 16685248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a unit risk factor for 1,3-butadiene based on an updated carcinogenic toxicity assessment.
    Grant RL; Haney J; Curry AL; Honeycutt M
    Risk Anal; 2009 Dec; 29(12):1726-42. PubMed ID: 19878488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-to-tumour risk assessment for 1,3-butadiene based on exposure of mice to low doses by inhalation.
    Dankovic DA; Smith RJ; Stayner LT; Bailer AJ
    IARC Sci Publ; 1993; (127):335-44. PubMed ID: 8070880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the potential risk to workers from exposure to 1,3-butadiene.
    Turnbull D; Rodricks JV; Brett SM
    Environ Health Perspect; 1990 Jun; 86():159-71. PubMed ID: 2205486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and epidemiology of 1,3-butadiene.
    Himmelstein MW; Acquavella JF; Recio L; Medinsky MA; Bond JA
    Crit Rev Toxicol; 1997 Jan; 27(1):1-108. PubMed ID: 9115622
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
    Albertini RJ; Sram RJ; Vacek PM; Lynch J; Rossner P; Nicklas JA; McDonald JD; Boysen G; Georgieva N; Swenberg JA
    Chem Biol Interact; 2007 Mar; 166(1-3):63-77. PubMed ID: 16949064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.